ArticleClinical drug investigation2018

Pharmacokinetics and Safety After a Single Dose of Imarikiren in Subjects with Renal or Hepatic Impairment.

Yukio Shimasaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.